Gabather AB (publ) (STO:GABA)
0.0240
-0.0004 (-1.64%)
Oct 9, 2026, 5:29 PM CET
Gabather AB Market Cap
Gabather AB has a market cap or net worth of 14.65 million as of October 9, 2026. It is the 48,710th most valuable company in the world and the 770th biggest in Sweden. Its market cap has increased by 87.97% in one year.
Market Cap
14.65M
Enterprise Value
10.97M
Revenue
n/a
Global Rank
Country Rank
#770 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2014, Gabather AB's market cap has decreased from 43.24M to 14.65M, a decrease of -66.12%. That is a compound annual growth rate of -8.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 14.65M | 30.60% |
| Dec 30, 2025 | 11.22M | 18.25% |
| Dec 30, 2024 | 9.49M | -54.20% |
| Dec 29, 2023 | 20.71M | -66.45% |
| Dec 30, 2022 | 61.73M | 1.64% |
| Dec 30, 2021 | 60.74M | -19.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.16B |
| Dicot Pharma AB | 816.53M |
| EQL Pharma AB | 688.04M |
| Cinclus Pharma Holding AB | 618.02M |
| Moberg Pharma AB | 525.59M |
| Enzymatica AB | 412.65M |
| Orexo AB | 262.72M |
| Klaria Pharma Holding AB (publ.) | 139.96M |